ANI PHARMACEUTICALS INC (ANIP) › Shareholders' EquityANI PHARMACEUTICALS INC (ANIP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $13.83M2009: $15.83M2010: $19.15M2011: -$34.28M2012: -$42.72M2013: $40.96M2014: $139.78M2015: $160.08M2016: $169.65M2017: $174.76M2018: $197.26M2019: $212.79M2020: $195.70M2021: $333.89M2022: $313.69M2023: $432.75M2024: $403.68M2025: $540.72M$540.72M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$540.72M+33.9%2024$403.68M-6.7%2023$432.75M+38.0%2022$313.69M-6.0%2021$333.89M+70.6%2020$195.70M-8.0%2019$212.79M+7.9%2018$197.26M+12.9%2017$174.76M+3.0%2016$169.65M+6.0%2015$160.08M+14.5%2014$139.78M+241.3%2013$40.96M+195.9%2012-$42.72M-24.6%2011-$34.28M-279.1%2010$19.15M+21.0%2009$15.83M+14.5%2008$13.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share